Dr. Daniel Looi Qi Hao is the Chief Scientific Officer of My CytoHealth Sdn. Bhd. At the same time, he is also appointed as an Honorary Lecturer in Faculty of Medicine, University Malaysia and Adjunct Lecturer in the Faculty of Medicine, MAHSA University. Currently, he has many active research collaborations with Universiti Kebangsaan Malaysia, University Malaya, Universiti Putra Malaysia, Institute of Medical Research, Monash University Malaysia, Taylor’s University and other institutions on the development of various treatments in the field of regenerative medicine. He has published more than 20 papers in international peer-reviewed journals and 3 patents on exosome isolation from stem cell and downstream application of exosome. Dr. Daniel also served as editor for several international scientific journals such as International Journal of Genetics and Genomics (IJGG), Acta Scientific Pharmacology, Journal of Clinical Images and Medical Case Reports and Journal of Asia Pacific Aesthetic Sciences. Currently, Dr. Daniel is focusing in the clinical development of stem cell-based therapy and biomaterial for dermatological and orthopedic application such as knee joint injury, wound care management and medical aesthetic. Dr. Daniel is also a profound member of various professional bodies including Tissue Engineering and Regenerative Medicine Society of Malaysia (TESMA), Tissue Engineering and Regenerative Medicine Society (TERMIS), Stem Cell Society Singapore (SCSS) as well as serving as a council member of Malaysian Society for Stem Cell Research and Therapy. Besides of research and academic, Dr. Daniel also provided medical advices for UOA Group, Gnosis laboratory (Malaysia) and NADI Healthcare Berhad.